American Heart Journal
Volume 158, Issue 1 , Pages 141-148.e1 , July 2009

Renal function, atherothrombosis extent, and outcomes in high-risk patients

  • Raphaelle L. Dumaine, MD

      Affiliations

    • Pitié-Salpêtrière University Hospital, Paris, France
    • ,
  • Gilles Montalescot, MD, PhD

      Affiliations

    • Pitié-Salpêtrière University Hospital, Paris, France
    • Corresponding Author InformationReprint requests: Gilles Montalescot, MD, PhD, Institut de Cardiologie, CHU Pitié-Salpêtrière, 47 boul de l'Hôpital, 75013 Paris, France.
    • ,
  • Ph. Gabriel Steg, MD

      Affiliations

    • Bichat-Claude Bernard University Hospital, Paris, France
    • ,
  • E. Magnus Ohman, MD

      Affiliations

    • Duke University, Durham, NC
    • ,
  • Kim Eagle, MD

      Affiliations

    • University of Michigan Cardiovascular Center, Ann Arbor, MI
    • ,
  • Deepak L. Bhatt, MD, MPH

      Affiliations

    • VA Boston Healthcare System and Brigham and Women's Hospital, Boston, MA
    • ,
  • on behalf of the REACH Registry Investigators

Received 10 December 2008 ,Accepted 2 May 2009.

  • Image Result

    Main medications used depending on renal function. RX, Therapies; HTN, antihypertensive.

    Main medications used depending on renal function. RX, Therapies; HTN, antihypertensive.

  • Image Result

    Antiplatelet therapy prescription stratified by number of atherothrombotic beds affected and creatinine clearance subgroups.

    Antiplatelet therapy prescription stratified by number of atherothrombotic beds affected and creatinine clearance subgroups.

  • Image Result

    Main adverse atherothrombotic events involving the 3 arterial beds at 1 year among creatinine clearance subgroups.

    Main adverse atherothrombotic events involving the 3 arterial beds at 1 year among creatinine clearance subgroups.

  • Image Result

    Association between severe chronic kidney disease and adverse outcomes at 1-year follow-up. *Adjusted risk of outcome for severely impaired creatinine clearance versus normal renal function as detaile

    Association between severe chronic kidney disease and adverse outcomes at 1-year follow-up. *Adjusted risk of outcome for severely impaired creatinine clearance versus normal renal function as detailed in the Methods section.

 See Appendix (available online) for a complete listing of REACH Registry Investigators.

PII: S0002-8703(09)00355-X

doi: 10.1016/j.ahj.2009.05.011

American Heart Journal
Volume 158, Issue 1 , Pages 141-148.e1 , July 2009

Article Tools

* Image Usage & Resolution